David A. Siegel Neuro Pace Inc Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Neuro Pace Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 20,900 shares of NPCE stock, worth $274,208. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,900
Previous 10,500
99.05%
Holding current value
$274,208
Previous $117,000
118.8%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NPCE
# of Institutions
94Shares Held
29.9MCall Options Held
1.8KPut Options Held
300-
Kck Ltd. Tortola, D85.27MShares$69.2 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$44.7 Million1.3% of portfolio
-
Polar Capital Holdings PLC London, X02.97MShares$39 Million0.24% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.61MShares$34.2 Million2.65% of portfolio
-
Morgan Stanley New York, NY2.53MShares$33.2 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $326M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...